Wednesday, December 15, 2010Drug FormulationsProjects Today News
Illustrative image – not actual.
Reckitt Benckiser Group, a Britian based consumer goods company and maker
of Dettol and Disprin, are expected to buy Ahmedabad based Paras
Pharmaceuticals. The deal is expected to be worth Rs 3,260 crore.
Aventis Pharma will sell its 49 per cent stake in Chiron Behring Vaccines
to its JV partner, Novartis Vaccines & Diagnostics Inc, for $22.4 million
(nearly Rs 100 crore).
NMDC has decided to set up a three million tpa integrated green field
steel plant at Nagarnar, Chhattisgarh at a cost of around Rs 15,525 crore.